Health

Recall Notice - SD Biosensor, Inc. requests discontinuation of use and disposal of specific Pilot™ COVID-19 At-Home Tests in the United States due to microbial contamination in the liquid buffer solution

SEOUL, South Korea, May 4, 2023 /PRNewswire/ -- SD Biosensor, Inc. today is requesting that consumers stop using and dispose of specific Pilot COVID-19 At-Home Tests inthe United States because potentially harmful bacteria were found in the tube with liquid inside (pouch 2 of the kits). The affe...

2023-05-05 04:00 2199

ABM Announces First Patient Dosed in Phase I Clinical Trial of MEK Inhibitor for Solid Tumor

SAN DIEGO and SHANGHAI, May 4, 2023 /PRNewswire/ -- ABM Therapeutics, an innovative clinical-stage biopharmaceutical company, with an emphasis on developing drugs with high blood–brain barrier (BBB) penetration for CNS diseases including brain metastases, today announced that the first patient wa...

2023-05-05 01:00 2538

DetectedX's Radiology Online Learning Centre Passes 4,500 Users

DetectedX will Showcase New Interactive Educational Technology at SBI NATIONAL HARBOR, Md., May 4, 2023 /PRNewswire/ -- DetectedX, the leaders in intelligent interactive educational technology, announced today that it has surpassed 4,500 users of its Radiology Online Learning Centre. Users, whic...

2023-05-04 23:25 2255

Momcozy Mother's Day Deal: Choose America's Top-selling Wearable Breast Pump Chosen by 2 Million Moms

NEW YORK, May 4, 2023 /PRNewswire/ -- Momcozy, the #1 selling wearable breast pump brand inNorth America, has announced a series of irresistible deals in celebration of Mother's Day. SinceMay 4th , whether on Momcozy's website , Amazon

2023-05-04 14:59 1977

Hasten Biopharma Acquires Commercial Rights in China for Roche's Antibiotic Rocephin®

The acquisition will deliver strong commercial synergy with Hasten's current critical care portfolio SHANGHAI, May 4, 2023 /PRNewswire/ -- Hasten Biopharmaceutic Co., Ltd (China) ("Hasten") today announced that it has acquired the commercial rights inChina for Rocephin®, a long-acting, broad spe...

2023-05-04 14:00 2114

Full-Life Technologies Announces Land Purchase in Belgium to Establish GMP Manufacturing Facility for Radiopharmaceutical Drug Production

GEMBLOUX, Belgium, May 3, 2023 /PRNewswire/ -- Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today is pleased to announce that it has closed on an important land purchase in Wallonia,Belgium, and signed a purchase agreement to build a state-of-the-art, ...

2023-05-04 10:00 1881

EDAN Announces Integration with PointClickCare for Better Senior Primary Care

SAN DIEGO, May 3, 2023 /PRNewswire/ -- Edan Instruments, Inc. (300206.SZ), a leading healthcare company and medical devices manufacturer, recently announced its integration with PointClickCare through its newly launched informatics solutions Allink. The solution ...

2023-05-03 21:56 2714

Skyline Therapeutics to Present at the ASGCT 26th Annual Meeting

SHANGHAI, May 3, 2023 /PRNewswire/ -- Skyline Therapeutics, an innovation-driven gene therapy company dedicated to developing unique and novel solutions to address unmet needs in rare and severe diseases, today announced multiple data presentations at the American Society of Gene and Cell Therapy...

2023-05-03 12:00 1969

China Jo-Jo Drugstores Receives Hangzhou Municipal People's Government Quality Management Excellence Award

HANGZHOU, China, May 2, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that the Co...

2023-05-02 20:30 3310

Mintal Tracker Honored as Bronze Stevie® Award Winner in 2023 American Business Awards®

Mintal Tracker was recognized for providing users with an easy way to achieve healthier sleep SAN FRANCISCO, May 1, 2023 /PRNewswire/ -- Mintal Tracker, a sleep tracking app driven by artificial intelligence (AI) technology that offers a scientific approach to healthier sleep, was named the winn...

2023-05-01 23:00 1639

Health Canal Survey: Why Older Adults are Hesitant to Receive the Bivalent Booster Shot

New survey by Health Canal reveals that personal health and safety concerns drive older adults' intentions and attitudes toward bivalent booster shots GROVE CITY, Ohio, May 1, 2023 /PRNewswire/ -- The CDC has recommended the bivalent mRNA COVID-19 vaccines sinceSep...

2023-05-01 22:00 1959

Meihua International Medical Technologies Co., Ltd.'s Subsidiary Completes Purchase of Land Use Right of Nearly 50,000 Square Meters in Hainan Free Trade Port Boao Hope City for the Construction of Integrated Medical Industrial Park

YANGZHOU, China, May 1, 2023 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries inChina, today announced the Company, via ...

2023-05-01 20:30 3790

I-MAB Filed 2022 Annual Report on Form 20-F

GAITHERSBURG, Md. and SHANGHAI, May 1, 2023 /PRNewswire/ -- I-Mab ("I-Mab" or the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that it has filed its annual report on Form 20...

2023-05-01 20:00 2137

OBiO and CHINAGENE reached a strategic agreement of commercial manufacturing services for gene therapy products

SHANGHAI, April 29, 2023 /PRNewswire/ -- On April 21, 2023, OBiO Technology ( Shanghai) Corp., Ltd. (OBiO) announced a strategic agreement of commercial manufacturing collaboration with CHINAGENE. Under the agreement, OBiO will provide holistic contract development and manufacturing services to CH...

2023-04-29 23:20 4312

ISS Collaboration - Singleron Biotechnologies GmbH joined the pursuit of "Reaching for the Stars"

MSIDA, Malta, April 28, 2023 /PRNewswire/ -- Yesterday, the celebrations for the MALETH project took place with a special keynote presentation from Dr.James Green, NASA's Former Chief Scientist. From Singleron, Dr. Samuel Kerr joined to present the yeast research studies aboard the International ...

2023-04-28 20:56 2129

HanAll Biopharma Reports First Quarter Results and Provides Business Update

* Financial results for the first quarter ended with revenue of KRW 28.8 billion, up by 20 percent compared to the same period in 2022 * HanAll made a strong start to 2023 with positive Phase 3 study results of anti-FcRn asset batoclimab for the treatment of generalized myasthenia gravis in C...

2023-04-28 19:00 2951

IMG-004 demonstrated extended half-life and durable pharmacodynamic characteristics in a Phase 1 study

SAN DIEGO, SHANGHAI and SYDNEY, April 28, 2023 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene") today announced positive topline results from a Phase 1 study evaluating IMG-004 in healthy participants. IMG-004 is a potent, non-covalent, reversible, and brain permeable third-generation Br...

2023-04-28 17:00 1863

United Imaging Healthcare delivers its first annual report since going public, with revenue growth of nearly 30% in 2022

Along with the publication of its 2022 annual report and its first quarter report for 2023, United Imaging Healthcare released its ESG report today. SHANGHAI, April 28, 2023 /PRNewswire/ -- United Imaging Healthcare achieved a YoY revenue growth of 27.36 %, a figure published in the company's 202...

2023-04-28 15:53 1812

WuXi Biologics Releases 2022 ESG Report Detailing Its Continued Commitment to Sustainability

* The Report outlines new goals of net-zero GHG emissions across all operations by 2050 and a 10% reduction of waste intensity by 2027 compared with 2022. * The Company makes remarkable progress on environmental goals, achieving its water consumption intensity-reduction target in 2022, well a...

2023-04-28 14:43 2950

Daewoong Pharmaceutical announces a Global License Agreement for DWP213388, a new drug candidate for autoimmune disease with Vitalli Bio

- Exclusive rights for the development and commercialization of DWP213388 in the global market to Vitalli Bio, a portfolio company of Aditum Bio, the biotech investment firm - Targeting the KRW 146 trillion global autoimmune disease market with partner who has top global drug development expertis...

2023-04-28 08:58 2124
1 ... 99100101102103104105 ... 280